摘要
[目的]观察苦参素联合胎盘肽治疗慢性乙型肝炎的临床疗效。[方法]对慢性乙型肝炎80例,随机分为苦参素联合胎盘肽为治疗组和苦参素为对照组各40例。观察两组患者的症状、体征、肝功能及乙肝病毒标志的变化。[结果]治疗组的HBeAg和HBVDAN的阴转率高于对照组,差异有显著性(P<0·05)。[结论]苦参素联合胎盘肽治疗慢性乙型肝炎较单用苦参素好。
[Objective] Observe the clinical curative effect of kurarinone and placenta peptide on chronic hepatitis Ⅱ. [Method] Randomly divide 80 cases hepatitis Ⅱ into treatment group of kurarinone and placenta peptide and control group of kurarinone, 40 cases in each group. Observe both＇s changes of symptoms, signs, liver function and virus symbol. [Result] The negative-transfer rate of HbeAg and HBVDAN is higher than control group, there＇s obvious difference. [Conclusion] It is better to treat chronic hepatitis Ⅱ with placenta peptide and kurarinone than only kurarinone.
出处
《浙江中医学院学报》
2006年第1期48-49,共2页
Journal of Zhejiang College of Traditional Chinese Medicine
关键词
慢性乙型肝炎
苦参素
胎盘肽
治疗
chronic hepatitis, kurarinone, placenta peptide, treatment
